Rotavirus Vaccine Effectiveness and Case-control Study on Risk Factors for Breakthrough Infections in Germany, 2010–2011

Background: In the German federal state Mecklenburg-Western Pomerania, routine rotavirus (RV) vaccination in infants has been recommended since 2009. The effectiveness of RV vaccination was investigated after an unexpectedly high number of RV infections in fully vaccinated children occurred. Methods: Intensified RV surveillance was performed in Mecklenburg-Western Pomerania between 2010 and 2011. The screening method was applied to assess vaccine effectiveness (VE) in children up to 24 months after vaccination. To identify risk factors for breakthrough infections, a case-control study and genotyping were conducted in vaccinated and unvaccinated RV-infected children. Results: VE for the prevention of RV infection requiring medical attention or hospitalization was 68% (95% confidence interval [CI]: 61–71) and 80% (95% CI: 77–83), respectively. VE for preventing hospitalization but not medical attention remained stable over 2 years. Vaccinated were less often hospitalized (23%) than unvaccinated RV-infected children (61%; P < 0.001). Breastfeeding (odds ratio, 3.99; 95% CI: 1.92–8.27) and attending daycare (odds ratio, 3.42; 95% CI: 1.64–7.12) were independently associated with breakthrough infections. Genotype G1P[8] was detected more frequently in RotaTeq-vaccinated (44% versus 11%; P < 0.03) and G2P[4] in Rotarix-vaccinated children (42% versus 6%; P < 0.02). Conclusions: RV vaccination protects young children effectively from RV disease and can reduce disease severity. Breastfeeding might impair VE, but further research is needed to identify the critical time window for this interference and to develop appropriate recommendations.

[1]  M. an der Heiden,et al.  Impact of rotavirus vaccination in regions with low and moderate vaccine uptake in Germany , 2012, Human vaccines & immunotherapeutics.

[2]  T. Vesikari,et al.  Efficacy and Immunogenicity of Live-attenuated Human Rotavirus Vaccine in Breast-fed and Formula-fed European Infants , 2012, The Pediatric infectious disease journal.

[3]  J. Tate,et al.  2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. , 2012, The Lancet. Infectious diseases.

[4]  J. Koch,et al.  Epidemiology of Rotavirus Infections in Children Less Than 5 Years of Age: Germany, 2001–2008 , 2011, The Pediatric infectious disease journal.

[5]  R. Triasih,et al.  Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries? , 2011, Vaccine.

[6]  J. Carapetis,et al.  Case-control evaluation of the effectiveness of the G1P[8] human rotavirus vaccine during an outbreak of rotavirus G2P[4] infection in central Australia. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Benjamin A Lopman,et al.  Uptake, Impact, and Effectiveness of Rotavirus Vaccination in the United States: Review of the First 3 Years of Postlicensure Data , 2011, The Pediatric infectious disease journal.

[8]  S. Lambert,et al.  Reduction in Rotavirus-associated Acute Gastroenteritis Following Introduction of Rotavirus Vaccine Into Australia's National Childhood Vaccine Schedule , 2011, The Pediatric infectious disease journal.

[9]  J. Matthijnssens,et al.  Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. , 2010, Vaccine.

[10]  R. Glass,et al.  Inhibitory Effect of Breast Milk on Infectivity of Live Oral Rotavirus Vaccines , 2010, The Pediatric infectious disease journal.

[11]  T. Dallman,et al.  Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance network , 2010, Epidemiology and Infection.

[12]  Manish M Patel,et al.  Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study , 2010, BMJ : British Medical Journal.

[13]  G. Koch,et al.  Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5) , 2010, BMC pediatrics.

[14]  Manish M Patel,et al.  Effectiveness of Pentavalent Rotavirus Vaccine in a Large Urban Population in the United States , 2010, Pediatrics.

[15]  M. Kundi,et al.  Universal Mass Vaccination Against Rotavirus Gastroenteritis: Impact on Hospitalization Rates in Austrian Children , 2009, The Pediatric infectious disease journal.

[16]  Manish M Patel,et al.  Oral rotavirus vaccines: how well will they work where they are needed most? , 2009, The Journal of infectious diseases.

[17]  T. Dallman,et al.  Rotavirus surveillance in europe, 2005-2008: web-enabled reporting and real-time analysis of genotyping and epidemiological data. , 2009, The Journal of infectious diseases.

[18]  Manish M Patel,et al.  Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. , 2009, JAMA.

[19]  A. Gervaix,et al.  The Search for Adenovirus 14 in Children in Houston, Texas , 2008, The Pediatric infectious disease journal.

[20]  Felix Espinoza,et al.  Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study , 2008, The Lancet.

[21]  L. Cuevas,et al.  Predominance of Rotavirus P[4]G2 in a Vaccinated Population, Brazil , 2007, Emerging infectious diseases.

[22]  J. Benzler,et al.  SurvNet Electronic Surveillance System for Infectious Disease Outbreaks, Germany , 2007, Emerging infectious diseases.

[23]  S. Diedrich,et al.  Group A rotavirus genotypes in Germany during 2005/2006 , 2007, Archives of Virology.

[24]  C. Lange,et al.  [Distribution, duration and temporal trend of breastfeeding in Germany. Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)]. , 2007, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.

[25]  L. Schenk,et al.  Verbreitung, Dauer und zeitlicher Trend des Stillens in Deutschland , 2007, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

[26]  G. Krause,et al.  Falldefinitionen für die Surveillance meldepflichtiger Infektionskrankheiten in Deutschland, Ausgabe 2007 , 2006, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

[27]  J. Benzler,et al.  SurvNet@RKI - a multistate electronic reporting system for communicable diseases. , 2006, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[28]  T. Vesikari,et al.  Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. , 2006, The New England journal of medicine.

[29]  C. Giaquinto,et al.  Clinical Trials of Rotavirus Vaccines in Europe , 2006, The Pediatric infectious disease journal.

[30]  R. Ward,et al.  Comparative Evaluation of Safety and Immunogenicity of Two Dosages of an Oral Live Attenuated Human Rotavirus Vaccine , 2005, The Pediatric infectious disease journal.

[31]  T. Vesikari,et al.  Efficacy of RIX4414 Live Attenuated Human Rotavirus Vaccine in Finnish Infants , 2004, The Pediatric infectious disease journal.

[32]  T. Vesikari,et al.  A Rotavirus Vaccine for Prophylaxis of Infants Against Rotavirus Gastroenteritis , 2004, The Pediatric infectious disease journal.

[33]  J. Sobel,et al.  Pathogen-specific risk factors and protective factors for acute diarrheal illness in children aged 12-59 months in São Paulo, Brazil. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  Y. V. van Duynhoven,et al.  Risk Factors for Norovirus, Sapporo-like Virus, and Group A Rotavirus Gastroenteritis , 2003, Emerging infectious diseases.

[35]  G. Kang,et al.  Evidence for Genetic Linkage between the Gene Segments Encoding NSP4 and VP6 Proteins in Common and Reassortant Human Rotavirus Strains , 2003, Journal of Clinical Microbiology.

[36]  Jennifer A. Roberts,et al.  A study of infectious intestinal disease in England: risk factors associated with group A rotavirus in children , 2001, Epidemiology and Infection.

[37]  J. Jaakkola,et al.  Day-care centers and diarrhea: a public health perspective. , 1997, The Journal of pediatrics.

[38]  M. Rennels.  Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines. , 1996, The Journal of infectious diseases.

[39]  C. Farrington.  Estimation of vaccine effectiveness using the screening method. , 1993, International journal of epidemiology.

[40]  R. Sack,et al.  Rotavirus diarrhoea in Apache children: a case-control study. , 1990, International journal of epidemiology.

[41]  Subhash Datta,et al.  OR in developing countries , 1988 .

[42]  T. Vesikari,et al.  Oral Rotavirus Vaccination in Breast‐ and Bottle‐Fed Infants Aged 6 to 12 Months , 1986, Acta paediatrica Scandinavica.

[43]  T. Vesikari,et al.  Dose-response study of RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants. , 1985, Pediatric infectious disease.

[44]  K. Starko,et al.  Diarrheal illness among infants and toddlers in day care centers. II. Comparison with day care homes and households. , 1985, The Journal of pediatrics.

[45]  J. Stockman,et al.  Safety and Efficacy of a Pentavalent Human-Bovine (WC3) Reassortant Rotavirus Vaccine , 2007 .

[46]  G. Poggensee,et al.  [On the 2007 edition of case definitions for the surveillance of notifiable infectious diseases in Germany]. , 2006, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.

[47]  P. Morrison,et al.  Exclusive breastfeeding is best in all cases. , 2002, Bulletin of the World Health Organization.

[48]  R. Reves,et al.  Child day care increases the risk of clinic visits for acute diarrhea and diarrhea due to rotavirus. , 1993, American journal of epidemiology.

[49]  T. Vesikari,et al.  Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. , 1990, Scandinavian journal of infectious diseases.